MOREPEN LABORATORIES
Back to Income Statement
|
MOREPEN LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,812 Cr | ₹1,690 Cr | ₹1,418 Cr | ₹1,547 Cr | ₹1,188 Cr |
What is the latest Revenue of MOREPEN LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,812 Cr |
| Mar2025 | ₹1,690 Cr |
| Mar2024 | ₹1,418 Cr |
| Mar2023 | ₹1,547 Cr |
| Mar2022 | ₹1,188 Cr |
How is Revenue of MOREPEN LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,812 Cr | 7.17 | |
| Mar2025 | ₹1,690 Cr | 19.25 | |
| Mar2024 | ₹1,418 Cr | -8.36 | |
| Mar2023 | ₹1,547 Cr | 30.20 | |
| Mar2022 | ₹1,188 Cr | - | |
Compare Revenue of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹5,170.4 Cr | -8.1% | -30.9% | 90.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -8.1% |
-30.9% |
90.8% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses